Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals

To support the deployment of serology assays for population screening during the COVID-19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG assays: Mindray CL-900i<sup>®</sup> (target: spike [S] and nucleocapsid [N]), BioMérieux VIDAS<sup>®</sup>3...

Full description

Bibliographic Details
Main Authors: Salma Younes, Hadeel Al-Jighefee, Farah Shurrab, Duaa W. Al-Sadeq, Nadin Younes, Soha R. Dargham, Nader Al-Dewik, Hamda Qotba, Mohamed Syed, Ahmed Alnuaimi, Hadi M. Yassine, Patrick Tang, Laith J. Abu-Raddad, Gheyath K. Nasrallah
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/9/2/245
id doaj-ca41e91601e3439099586db49bd8e661
record_format Article
spelling doaj-ca41e91601e3439099586db49bd8e6612021-01-26T00:05:28ZengMDPI AGMicroorganisms2076-26072021-01-01924524510.3390/microorganisms9020245Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 IndividualsSalma Younes0Hadeel Al-Jighefee1Farah Shurrab2Duaa W. Al-Sadeq3Nadin Younes4Soha R. Dargham5Nader Al-Dewik6Hamda Qotba7Mohamed Syed8Ahmed Alnuaimi9Hadi M. Yassine10Patrick Tang11Laith J. Abu-Raddad12Gheyath K. Nasrallah13Biomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation–Education City, Doha P.O. Box 24144, QatarClinical and Metabolic Genetics Section, Pediatrics Department, Hamad General Hospital (HGH), Hamad Medical Corporation, Doha P.O. Box 3050, QatarDepartment of Clinical Research, Primary Health Care Centers, Doha P.O. Box 26555, QatarDepartment of Clinical Research, Primary Health Care Centers, Doha P.O. Box 26555, QatarDepartment of Clinical Research, Primary Health Care Centers, Doha P.O. Box 26555, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarDepartment of Pathology, Sidra Medicine, Doha P.O. Box 26999, QatarInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation–Education City, Doha P.O. Box 24144, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarTo support the deployment of serology assays for population screening during the COVID-19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG assays: Mindray CL-900i<sup>®</sup> (target: spike [S] and nucleocapsid [N]), BioMérieux VIDAS<sup>®</sup>3 (target: receptor-binding domain [RBD]) and Diasorin LIAISON<sup>®</sup>XL (target: S1 and S2 subunits). A total of 111 SARS-CoV-2 RT-PCR- positive samples collected at ≥ 21 days post symptom onset, and 127 pre-pandemic control samples were included. Diagnostic performance was assessed in correlation to RT-PCR and a surrogate virus-neutralizing test (sVNT). Moreover, cross-reactivity with other viral antibodies was investigated. Compared to RT-PCR, LIAISON<sup>®</sup>XL showed the highest overall specificity (100%), followed by VIDAS<sup>®</sup>3 (98.4%) and CL-900i<sup>®</sup> (95.3%). The highest sensitivity was demonstrated by CL-900i<sup>®</sup> (90.1%), followed by VIDAS<sup>®</sup>3 (88.3%) and LIAISON<sup>®</sup>XL (85.6%). The sensitivity of all assays was higher in symptomatic patients (91.1–98.2%) compared to asymptomatic patients (78.4–80.4%). In correlation to sVNT, all assays showed excellent sensitivities (92.2–96.1%). In addition, VIDAS<sup>®</sup>3 demonstrated the best correlation (r = 0.75) with the sVNT. The present study provides insights on the performance of three fully automated assays, which could help diagnostic laboratories in the choice of a particular assay according to the intended use.https://www.mdpi.com/2076-2607/9/2/245COVID-19SARS-CoV-2serologysensitivityspecificityneutralizing antibodies
collection DOAJ
language English
format Article
sources DOAJ
author Salma Younes
Hadeel Al-Jighefee
Farah Shurrab
Duaa W. Al-Sadeq
Nadin Younes
Soha R. Dargham
Nader Al-Dewik
Hamda Qotba
Mohamed Syed
Ahmed Alnuaimi
Hadi M. Yassine
Patrick Tang
Laith J. Abu-Raddad
Gheyath K. Nasrallah
spellingShingle Salma Younes
Hadeel Al-Jighefee
Farah Shurrab
Duaa W. Al-Sadeq
Nadin Younes
Soha R. Dargham
Nader Al-Dewik
Hamda Qotba
Mohamed Syed
Ahmed Alnuaimi
Hadi M. Yassine
Patrick Tang
Laith J. Abu-Raddad
Gheyath K. Nasrallah
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
Microorganisms
COVID-19
SARS-CoV-2
serology
sensitivity
specificity
neutralizing antibodies
author_facet Salma Younes
Hadeel Al-Jighefee
Farah Shurrab
Duaa W. Al-Sadeq
Nadin Younes
Soha R. Dargham
Nader Al-Dewik
Hamda Qotba
Mohamed Syed
Ahmed Alnuaimi
Hadi M. Yassine
Patrick Tang
Laith J. Abu-Raddad
Gheyath K. Nasrallah
author_sort Salma Younes
title Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
title_short Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
title_full Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
title_fullStr Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
title_full_unstemmed Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
title_sort diagnostic efficiency of three fully automated serology assays and their correlation with a novel surrogate virus neutralization test in symptomatic and asymptomatic sars-cov-2 individuals
publisher MDPI AG
series Microorganisms
issn 2076-2607
publishDate 2021-01-01
description To support the deployment of serology assays for population screening during the COVID-19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG assays: Mindray CL-900i<sup>®</sup> (target: spike [S] and nucleocapsid [N]), BioMérieux VIDAS<sup>®</sup>3 (target: receptor-binding domain [RBD]) and Diasorin LIAISON<sup>®</sup>XL (target: S1 and S2 subunits). A total of 111 SARS-CoV-2 RT-PCR- positive samples collected at ≥ 21 days post symptom onset, and 127 pre-pandemic control samples were included. Diagnostic performance was assessed in correlation to RT-PCR and a surrogate virus-neutralizing test (sVNT). Moreover, cross-reactivity with other viral antibodies was investigated. Compared to RT-PCR, LIAISON<sup>®</sup>XL showed the highest overall specificity (100%), followed by VIDAS<sup>®</sup>3 (98.4%) and CL-900i<sup>®</sup> (95.3%). The highest sensitivity was demonstrated by CL-900i<sup>®</sup> (90.1%), followed by VIDAS<sup>®</sup>3 (88.3%) and LIAISON<sup>®</sup>XL (85.6%). The sensitivity of all assays was higher in symptomatic patients (91.1–98.2%) compared to asymptomatic patients (78.4–80.4%). In correlation to sVNT, all assays showed excellent sensitivities (92.2–96.1%). In addition, VIDAS<sup>®</sup>3 demonstrated the best correlation (r = 0.75) with the sVNT. The present study provides insights on the performance of three fully automated assays, which could help diagnostic laboratories in the choice of a particular assay according to the intended use.
topic COVID-19
SARS-CoV-2
serology
sensitivity
specificity
neutralizing antibodies
url https://www.mdpi.com/2076-2607/9/2/245
work_keys_str_mv AT salmayounes diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT hadeelaljighefee diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT farahshurrab diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT duaawalsadeq diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT nadinyounes diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT sohardargham diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT naderaldewik diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT hamdaqotba diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT mohamedsyed diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT ahmedalnuaimi diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT hadimyassine diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT patricktang diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT laithjaburaddad diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
AT gheyathknasrallah diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals
_version_ 1724323633787043840